Microbot Medical reports >100% revenue and customer growth for Q2 2026 vs Q1 2026

Microbot Medical Inc.

Revenue and new customers grew more than 100% in Q2 2026 compared to Q1 2026.
LIBERTY System adopted by leading health systems in Massachusetts, North Carolina, Michigan, and Pennsylvania.
Entered agreement with Lovell Government Services to serve federal healthcare systems including VHA, MHS, IHS.
Received marketing clearance for LIBERTY system from Israeli Ministry of Health, first international approval.
Plans to expand U.S. sales territories from 8 to 12 and enter international markets by end of 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.